Not applicableWithdrawnNCT02099149
What this trial is testing
Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Infants Aged Less Than 90 Days
Who this might be right for
Invasive Group B Streptococcus Disease
Novartis